VKH
EIGR

Virtu KCG Holdings’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Virtu KCG Holdings’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-66
Closed -$31K – 4034
2015
Q3 		$31K Sell
66
-264
-80% -$140K ﹤0.01% 3088
2015
Q2 		$187K Buy
+330
New +$913K ﹤0.01% 2634

Other funds holding EIGR

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu KCG Holdings's EIGR Position: Q4 2015 in Review

Virtu KCG Holdings sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q4 2015, closing a stake of 66 shares — an estimated $31K sold.

Virtu KCG Holdings first reported a position in EIGR in Q2 2015 and held it in 2 quarters. The position peaked at $187K in Q2 2015. 41 funds tracked by Wall St. Rank hold EIGR as of Q4 2015.

  • Virtu KCG Holdings reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Virtu KCG Holdings sold 66 Eiger BioPharmaceuticals, Inc. shares in Q4 2015, an estimated $31K.
  • Virtu KCG Holdings first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2015 and held it in 2 quarters.
  • Virtu KCG Holdings's Eiger BioPharmaceuticals, Inc. position peaked at $187K in Q2 2015.
  • 41 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2015.

Based on Virtu KCG Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.